{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:57:53Z","timestamp":1793055473015,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020043","name":"Yeditepe University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020043","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05550-w","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:50:23Z","timestamp":1777373423000},"page":"2399-2411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cannabidiol potentiates olaparib-induced cytotoxicity through cell cycle arrest and DNA damage modulation in breast cancer cells"],"prefix":"10.1007","volume":"481","author":[{"given":"Cans\u0131n","family":"Deniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fc\u015fra","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Cebeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikrettin","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"5550_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-7-7","author":"TN Seyfried","year":"2010","unstructured":"Seyfried TN, Shelton LM (2010) Cancer as a metabolic disease. Nutr Metab (Lond). https:\/\/doi.org\/10.1186\/1743-7075-7-7","journal-title":"Nutr Metab (Lond)"},{"issue":"3","key":"5550_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13304-017-0424-1","volume":"69","author":"Z Anastasiadi","year":"2017","unstructured":"Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M (2017) Breast cancer in young women: an overview. Updates Surg 69(3):313\u2013317","journal-title":"Updates Surg"},{"issue":"2","key":"5550_CR3","first-page":"435","volume":"49","author":"BI Simsek","year":"2024","unstructured":"Simsek BI, Halici H, Cadirci E (2024) Molecularly targeted therapies in breast cancer: a traditional review. Fabad J Pharm Sci 49(2):435\u2013448","journal-title":"Fabad J Pharm Sci"},{"issue":"5","key":"5550_CR4","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.7150\/thno.67530","volume":"12","author":"K Kwak","year":"2022","unstructured":"Kwak K, Yu B, Lewandowski RJ, Kim DH (2022) Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation. Theranostics 12(5):2175\u20132204","journal-title":"Theranostics"},{"issue":"2","key":"5550_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12013-014-0459-6","volume":"72","author":"ZQ Tao","year":"2015","unstructured":"Tao ZQ, Shi A, Lu C, Song T, Zhang Z, Zhao J (2015) Breast Cancer: Epidemiology and Etiology. Cell Biochem Biophys 72(2):333\u2013338","journal-title":"Cell Biochem Biophys"},{"issue":"11","key":"5550_CR6","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.7150\/ijbs.21635","volume":"13","author":"YS Sun","year":"2017","unstructured":"Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY et al (2017) Risk factors and preventions of breast cancer. Int J Biol Sci 13(11):1387\u20131397","journal-title":"Int J Biol Sci"},{"issue":"7","key":"5550_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.46747\/cfp.6807515","volume":"68","author":"SL Shuel","year":"2022","unstructured":"Shuel SL (2022) Targeted cancer therapies. Can Fam Physician 68(7):515\u2013518","journal-title":"Can Fam Physician"},{"issue":"03n04","key":"5550_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1142\/S2339547818300020","volume":"06","author":"P Krzyszczyk","year":"2018","unstructured":"Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M et al (2018) The growing role of precision and personalized medicine for cancer treatment. Technology 06(03n04):79\u2013100","journal-title":"Technology"},{"issue":"4","key":"5550_CR9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2023","unstructured":"Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK et al (2023) Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis 10(4):1367\u20131401","journal-title":"Genes Dis"},{"issue":"12","key":"5550_CR10","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1111\/tri.14115","volume":"34","author":"U Maggiore","year":"2021","unstructured":"Maggiore U, Palmisano A, Buti S, Claire Giudice G, Cattaneo D, Giuliani N et al (2021) Chemotherapy, targeted therapy and immunotherapy: which drugs can be safely used in the solid organ transplant recipients? Transplant Int 34(12):2442\u201358","journal-title":"Transplant Int"},{"key":"5550_CR11","doi-asserted-by":"crossref","unstructured":"Williamson EM, Evans FJ (2000) Cannabinoids in clinical practice. Centre for Pharmacognosy, The School of Pharmacy, University of London, London, England","DOI":"10.2165\/00003495-200060060-00005"},{"key":"5550_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/156800705774322111","volume":"4","author":"F Grotenhermen","year":"2005","unstructured":"Grotenhermen F (2005) Cannabinoids. Curr Drug Targets-CNS Neurol Disord 4:507\u201330","journal-title":"Curr Drug Targets-CNS Neurol Disord"},{"key":"5550_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147929","author":"A Jastrz\u0105b","year":"2022","unstructured":"Jastrz\u0105b A, Jarocka-Karpowicz I, Skrzydlewska E (2022) The origin and biomedical relevance of cannabigerol. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23147929","journal-title":"Int J Mol Sci"},{"key":"5550_CR14","unstructured":"Alger BE (2013) Getting high on the endocannabinoid system. Cerebrum"},{"key":"5550_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063344","author":"C Pagano","year":"2022","unstructured":"Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C (2022) Cannabinoids: therapeutic use in clinical practice. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23063344","journal-title":"Int J Mol Sci"},{"issue":"11","key":"5550_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12113203","volume":"12","author":"ES Seltzer","year":"2020","unstructured":"Seltzer ES, Watters AK, Mackenzie D, Granat LM, Zhang D (2020) Cannabidiol (Cbd) as a promising anti-cancer drug. Cancers (Basel) 12(11):1\u201326","journal-title":"Cancers (Basel)"},{"issue":"11","key":"5550_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1089\/acm.2017.0016","volume":"23","author":"V Bogdanovi\u0107","year":"2017","unstructured":"Bogdanovi\u0107 V, Mrdjanovi\u0107 J, Bori\u0161ev I (2017) A review of the therapeutic antitumor potential of cannabinoids. J Altern Complement Med 23(11):831\u2013836","journal-title":"J Altern Complement Med"},{"key":"5550_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012275","author":"L Thors","year":"2010","unstructured":"Thors L, Bergh A, Persson E, Hammarsten P, Stattin P, Egevad L et al (2010) Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0012275","journal-title":"PLoS One"},{"key":"5550_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071673","author":"T Kiskov\u00e1","year":"2019","unstructured":"Kiskov\u00e1 T, Mungenast F, Suv\u00e1kov\u00e1 M, J\u00e4ger W, Thalhammer T (2019) Future aspects for cannabinoids in breast cancer therapy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20071673","journal-title":"Int J Mol Sci"},{"key":"5550_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cells13020187","author":"D Mokoena","year":"2024","unstructured":"Mokoena D, George BP, Abrahamse H (2024) Cannabidiol combination enhances photodynamic therapy effects on MCF-7 breast cancer cells. Cells. https:\/\/doi.org\/10.3390\/cells13020187","journal-title":"Cells"},{"issue":"7","key":"5550_CR21","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1007\/s00432-022-04189-6","volume":"149","author":"A Mandapati","year":"2023","unstructured":"Mandapati A, Lukong KE (2023) Triple negative breast cancer: approved treatment options and their mechanisms of action. J Cancer Res Clin Oncol 149(7):3701\u20133719","journal-title":"J Cancer Res Clin Oncol"},{"key":"5550_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116045","author":"IM Bastos","year":"2024","unstructured":"Bastos IM, Rebelo S, Silva VLM (2024) A review of poly(ADP-ribose)polymerase-1 (PARP1) role and its inhibitors bearing pyrazole or indazole core for cancer therapy. Biochem Pharmacol. https:\/\/doi.org\/10.1016\/j.bcp.2024.116045","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"5550_CR23","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/annonc\/mdw142","volume":"27","author":"M Moschetta","year":"2016","unstructured":"Moschetta M, George A, Kaye SB, Banerjee S (2016) BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer. Ann Oncol 27(8):1449\u20131455","journal-title":"Ann Oncol"},{"issue":"3","key":"5550_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","volume":"33","author":"B Kaufman","year":"2015","unstructured":"Kaufman B, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balma\u00f1a J et al (2015) Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation. J Clin Oncol 33(3):244\u2013250","journal-title":"J Clin Oncol"},{"issue":"1","key":"5550_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1470-2045(14)71135-0","volume":"16","author":"AM Oza","year":"2015","unstructured":"Oza AM, Cibula D, Benzaquen AO, Poole C, Mathijssen RHJ, Sonke GS et al (2015) Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. Lancet Oncol 16(1):87\u201397","journal-title":"Lancet Oncol"},{"key":"5550_CR26","first-page":"5784","volume":"61","author":"C S\u00e1nchez","year":"2001","unstructured":"S\u00e1nchez C, de Ceballos ML, G\u00f3mez del Pulgar T, Rueda D, Corbacho C, Velasco G et al (2001) Inhibition of glioma growth in vivo by selective activation of the CB 2 cannabinoid receptor 1. Cancer Res 61:5784\u20135789","journal-title":"Cancer Res"},{"issue":"4","key":"5550_CR27","first-page":"910","volume":"14","author":"M Kapa\u0142czy\u0144ska","year":"2018","unstructured":"Kapa\u0142czy\u0144ska M, Kolenda T, Przyby\u0142a W, Zaj\u0105czkowska M, Teresiak A, Filas V et al (2018) 2D and 3D cell cultures \u2013 a comparison of different types of cancer cell cultures. Arch Med Sci 14(4):910\u20139","journal-title":"Arch Med Sci"},{"issue":"1","key":"5550_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01207-x","volume":"8","author":"EV Sazonova","year":"2022","unstructured":"Sazonova EV, Chesnokov MS, Zhivotovsky B, Kopeina GS (2022) Drug toxicity assessment: cell proliferation versus cell death. Cell Death Discov 8(1):417","journal-title":"Cell Death Discov"},{"key":"5550_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ab.2016.06.025","volume":"508","author":"S Aykul","year":"2016","unstructured":"Aykul S, Martinez-Hackert E (2016) Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysis. Anal Biochem 508:97\u2013103","journal-title":"Anal Biochem"},{"issue":"2","key":"5550_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s10495-016-1333-3","volume":"22","author":"G Banfalvi","year":"2017","unstructured":"Banfalvi G (2017) Methods to detect apoptotic cell death. Apoptosis 22(2):306\u2013323","journal-title":"Apoptosis"},{"key":"5550_CR31","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100934","author":"G Pistritto","year":"2016","unstructured":"Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D\u2019Orazi G (2016) Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging. https:\/\/doi.org\/10.18632\/aging.100934","journal-title":"Aging"},{"issue":"4","key":"5550_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a008656","volume":"5","author":"DR McIlwain","year":"2013","unstructured":"McIlwain DR, Berger T, Mak TW (2013) Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 5(4):1\u201328","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5550_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020812","author":"L Kolloch","year":"2022","unstructured":"Kolloch L, Kreinest T, Meisterernst M, Oeckinghaus A (2022) Control of expression of key cell cycle enzymes drives cell line-specific functions of CDK7 in human PDAC cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23020812","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5550_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02080-z","volume":"10","author":"I Pellarin","year":"2025","unstructured":"Pellarin I, Dall\u2019Acqua A, Favero A, Segatto I, Rossi V, Crestan N et al (2025) Cyclin-dependent protein kinases and cell cycle regulation in biology and disease. Signal Transduct Target Ther 10(1):11","journal-title":"Signal Transduct Target Ther"},{"issue":"15","key":"5550_CR35","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1038\/s41388-022-02239-4","volume":"41","author":"A Turdo","year":"2022","unstructured":"Turdo A, Gaggianesi M, Di Franco S, Veschi V, D\u2019Accardo C, Porcelli G et al (2022) Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51. Oncogene 41(15):2196\u20132209","journal-title":"Oncogene"},{"issue":"3","key":"5550_CR36","first-page":"1735","volume":"38","author":"K Yoshikawa","year":"2018","unstructured":"Yoshikawa K, Shimada M, Higashijima J, Nakao T, Nishi M, Takasu C et al (2018) Ki-67 and survivin as predictive factors for rectal cancer treated with preoperative chemoradiotherapy. Anticancer Res 38(3):1735\u20131739","journal-title":"Anticancer Res"},{"key":"5550_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.836417","author":"NM Almansour","year":"2022","unstructured":"Almansour NM (2022) Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2022.836417","journal-title":"Front Mol Biosci"},{"issue":"5","key":"5550_CR38","doi-asserted-by":"publisher","first-page":"e703","DOI":"10.1016\/j.cllc.2021.01.009","volume":"22","author":"T Waddington","year":"2021","unstructured":"Waddington T, Mambetsariev I, Pharaon R, Fricke J, Baroz AR, Romo H et al (2021) Therapeutic potential of olaparib in combination with pembrolizumab in a young patient with a maternally inherited BRCA2 germline variant: a research report. Clin Lung Cancer 22(5):e703\u2013e707","journal-title":"Clin Lung Cancer"},{"key":"5550_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biom11050766","author":"C Griffiths","year":"2021","unstructured":"Griffiths C, Aikins J, Warshal D, Ostrovsky O (2021) Can cannabidiol affect the efficacy of chemotherapy and epigenetic treatments in cancer? Biomolecules. https:\/\/doi.org\/10.3390\/biom11050766","journal-title":"Biomolecules"},{"issue":"3","key":"5550_CR40","first-page":"4010","volume":"15","author":"RC Brands","year":"2018","unstructured":"Brands RC, Scheurer MJJ, Hartmann T, Seher A, K\u00fcbler AC, M\u00fcller-Richter DA (2018) Apoptosis-sensitizing activity of birinapant in headand neck squamous cell carcinoma cell lines. Oncol Lett 15(3):4010\u20134016","journal-title":"Oncol Lett"},{"key":"5550_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188556","author":"LJ Hern\u00e1ndez Borrero","year":"2021","unstructured":"Hern\u00e1ndez Borrero LJ, El-Deiry WS (2021) Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochimica et Biophysica Acta (BBA). https:\/\/doi.org\/10.1016\/j.bbcan.2021.188556","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"5550_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112679","author":"ER Stead","year":"2021","unstructured":"Stead ER, Bjedov I (2021) Balancing DNA repair to prevent ageing and cancer. Exp Cell Res. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112679","journal-title":"Exp Cell Res"},{"issue":"10","key":"5550_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cells13100841","volume":"13","author":"F T\u00f3th","year":"2024","unstructured":"T\u00f3th F, Moftakhar Z, Sotgia F, Lisanti MP (2024) In vitro investigation of therapy-induced senescence and senescence escape in breast cancer cells using novel flow cytometry-based methods. Cells 13(10):841","journal-title":"Cells"},{"key":"5550_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-024-01589-4","author":"M Sk\u00f3rzewska","year":"2024","unstructured":"Sk\u00f3rzewska M, G\u0119ca K (2024) The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine. Curr Oncol Rep. https:\/\/doi.org\/10.1007\/s11912-024-01589-4","journal-title":"Curr Oncol Rep"},{"key":"5550_CR45","first-page":"113","volume":"17","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhang R, Li D (2023) Molecular biology mechanisms and emerging therapeutics of triple-negative breast cancer. Biologics 17:113\u2013128","journal-title":"Biologics"},{"key":"5550_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s12551-021-00821-w","author":"YM Efremov","year":"2021","unstructured":"Efremov YM, Zurina IM, Presniakova VS, Kosheleva NV, Butnaru DV, Svistunov AA et al (2021) Mechanical properties of cell sheets and spheroids: the link between single cells and complex tissues. Biophys Rev. https:\/\/doi.org\/10.1007\/s12551-021-00821-w","journal-title":"Biophys Rev"},{"issue":"7","key":"5550_CR47","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1021\/mp500002y","volume":"11","author":"TM Achilli","year":"2014","unstructured":"Achilli TM, McCalla S, Meyer J, Tripathi A, Morgan JR (2014) Multilayer spheroids to quantify drug uptake and diffusion in 3D. Mol Pharm 11(7):2071\u20132081","journal-title":"Mol Pharm"},{"key":"5550_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071505","author":"J Matta","year":"2017","unstructured":"Matta J, Ortiz C, Encarnaci\u00f3n J, Dutil J, Su\u00e1rez E (2017) Variability in DNA repair capacity levels among molecular breast cancer subtypes: Triple negative breast cancer shows lowest repair. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18071505","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5550_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/NS20200080","volume":"5","author":"SR Pereira","year":"2021","unstructured":"Pereira SR, Hackett B, O\u2019Driscoll DN, Sun MC, Downer EJ (2021) Cannabidiol modulation of oxidative stress and signaling. Neuronal Signal 5(3):1\u201318","journal-title":"Neuronal Signal"},{"key":"5550_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.782766","author":"AMK Law","year":"2021","unstructured":"Law AMK, Rodriguez de la Fuente L, Grundy TJ, Fang G, Valdes-Mora F, Gallego-Ortega D (2021) Advancements in 3D cell culture systems for personalizing anti-cancer therapies. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.782766","journal-title":"Front Oncol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05550-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05550-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05550-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:04:02Z","timestamp":1781773442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05550-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["5550"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05550-w","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}